Vanguard Group’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
|
|||||
|
2025
Q1 | $384K | Hold |
|
|||||
|
2024
Q4 | $1.03M | Sell |
|
|||||
|
2024
Q3 | $3.23M | Buy |
|
|||||
|
2024
Q2 | $3.69M | Sell |
|
|||||
|
2024
Q1 | $6.29M | Buy |
|
|||||
|
2023
Q4 | $5.22M | Buy |
|
|||||
|
2023
Q3 | $4.67M | Buy |
|
|||||
|
2023
Q2 | $8.02M | Buy |
|
|||||
|
2023
Q1 | $7.08M | Buy |
|
|||||
|
2022
Q4 | $4.75M | Buy |
|
|||||
|
2022
Q3 | $7.04M | Buy |
|
|||||
|
2022
Q2 | $5.28M | Sell |
|
|||||
|
2022
Q1 | $11.1M | Buy |
|
|||||
|
2021
Q4 | $9.51M | Buy |
|
|||||
|
2021
Q3 | $11.7M | Buy |
|
|||||
|
2021
Q2 | $19.7M | Buy |
|
|||||
|
2021
Q1 | $9.02M | Buy |
|
|||||
|
2020
Q4 | $770K | Buy |
|
|||||
|
2020
Q3 | $596K | Buy |
|
|||||
|
2020
Q2 | $609K | Buy |
|
|||||
|
2020
Q1 | $279K | Sell |
|
|||||
|
2019
Q4 | $477K | Hold |
|
|||||
|
2019
Q3 | $360K | Buy |
|
|||||
|
2019
Q2 | $444K | Buy |
|
|||||
|
2019
Q1 | $158K | Buy |
|
|||||
|
2018
Q4 | $56K | Buy |
|
|||||
|
2018
Q3 | $90K | Buy |
|
|||||
|
2018
Q2 | $113K | Buy |
|
|||||
|
2018
Q1 | $81K | Buy |
|
|||||
|
2017
Q4 | $43K | Buy |
|